Testing effectiveness (Phase 2)Ended earlyNCT02418325
What this trial is testing
Allogeneic Human UC-MSC and Liberation Therapy (When Associated With CCSVI) in Patients With RRMS
Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Genesis Limited 69